Earnings
ASLN
3.220
+6.27%
0.190
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
0.00
0.00
0.00
0.00
7.17M
9.31M
--
--
--
16.35M
--
-16.35M
-1.38M
970.00
755.78K
-622.60K
-16.97M
0.00
-16.97M
773.40K
-16.20M
-16.20M
--
--
-0.42
FY 2019-12-31
3.00M
3.00M
407.26K
2.59M
8.51M
16.59M
--
--
--
48.58M
--
-45.58M
-933.40K
-74.20K
-70.97K
-1.08M
-46.66M
408.00K
-47.07M
49.57K
-47.02M
-47.02M
--
--
-1.45
FY 2019-12-31
3.08M
3.08M
418.77K
2.67M
8.77M
17.09M
--
--
--
50.05M
--
-46.97M
-961.72K
-76.42K
-73.38K
-1.11M
-48.08M
420.37K
-48.50M
51.07K
-48.45M
-48.45M
--
--
-1.49
FY 2018-12-31
0.00
0.00
0.00
0.00
10.39M
31.46M
--
--
--
41.85M
--
-41.85M
-66.88K
--
241.70K
--
-41.67M
14.27K
-41.69M
--
-41.69M
-41.69M
--
--
-1.39
FY 2018-12-31
0.00
0.00
0.00
0.00
10.51M
31.83M
--
--
--
42.35M
--
-42.35M
-67.67K
0.00
244.59K
176.92K
-42.17M
14.44K
-42.19M
0.00
-42.19M
-42.19M
--
--
-1.41

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ASLN latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Aslan Pharms recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.